STRIASCAN sol inj 74 MBq/ml flac 2.5 ml

7680685930019 CH-68593 V09AB03 17.01.1.

Reimbursement limitations:

STRIASCAN

L’indication doit être posée par un spécialiste en neurologie (FMH).
Dans des cas sélectionnés pour …

STRIASCAN sol inj 74 MBq/ml flac 2.5 ml
STRIASCAN sol inj 74 MBq/ml flac 2.5 ml
STRIASCAN sol inj 74 MBq/ml flac 2.5 ml
1 / 3
google

Details

Product number
6859301
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
ioflupanum(123-I) zum Kalibrierungszeitpunkt 185 MBq, ioflupanum(127-I), ethanolum 98.75 mg, acidum aceticum, natrii acetas trihydricus corresp. natrium 4.9 mg, acidum phosphoricum concentratum, aqua ad iniectabile, q.s. ad solutionem pro 2.5 ml.

Articles (1)

Striascan 74 MBq/ml, Injektionslösung
Injektionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
11/04/2025
Professional SmPC
Français
11/04/2025
Professional SmPC
Italien
11/04/2025

Detailed composition

Substance Quantity Type Category
(N/A)
185.0 MBQ Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
98.75 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
4.9 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 891.85
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/05/2023

Authorization holder

b.e.imaging.ag

6430 Schwyz

Authorization information

Swissmedic authorization number
68593
Drug name
Striascan 74 MBq/ml, Injektionslösung
Galenic form
LSINJ
ATC Code
V09AB03
Authorization status
Z
Dispensation category
A
First authorization
09/09/2022
Authorization expiration date
08/09/2027
IT number
17.01.1.
Domain
Human medicine
Field of application
Untersuchung dopaminerger Neuronenendigungen im Striatum von Patienten mit klinisch unklaren Parkinson-Symptomen

Packaging details

Description (FR)
STRIASCAN sol inj 74 MBq/ml flac 2.5 ml
Description (DE)
STRIASCAN Inj Lös 74 MBq/ml Durchstf 2.5 ml
Market launch
09/09/2022
Narcotic (BTM)
No

Original drug

DaTSCAN TM 123 I-Ioflupane (INN), Injektionslösung
CHF 1084.05
View original